41/2025Trifork Group: Interim report for the quarter and half-year ending 30 June 2025
Company announcement no. 41/2025Schindellegi, Switzerland – 19 August 2025 Interim Financial Report…
ADNOC Gas Announces Record Second Quarter Performance, Demonstrating Resilience in Lower Price Environment
Highest-ever quarterly net income of $1.385 billion, up 16% YoY, reflects the…
Sonata Software Q1 FY26 Consolidated PAT Grew 1.7% QoQ, And Announces First Interim Dividend of Rupees 1.25 Per Share
MUMBAI, India, July 30, 2025 /PRNewswire/ -- Sonata Software (NSE: SONATSOFTW) (BSE:…
Emerald Clinical Trials Confirms CEO Transition and Continuity Plan
SINGAPORE, July 30, 2025 /PRNewswire/ -- Emerald Clinical Trials, a leading global…
Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop
– Phase 1a clinical data in healthy participants presented for both ABI-5366…
HUTCHMED to Announce 2025 Half-Year Financial Results
July 03, 2025 04:30 ET Â | Source: HUTCHMED (China) Limited HONG KONG…
National Science Teaching Association Welcomes New Board and Leadership Council Members
MCLEAN, Va.--(BUSINESS WIRE)--#NSTA--The National Science Teaching Association (NSTA) today announced the newest…
Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition…